Ahmad, I.M.; Dafferner, A.J.; O’Connell, K.A.; Mehla, K.; Britigan, B.E.; Hollingsworth, M.A.; Abdalla, M.Y.
Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers 2021, 13, 2264.
https://doi.org/10.3390/cancers13092264
AMA Style
Ahmad IM, Dafferner AJ, O’Connell KA, Mehla K, Britigan BE, Hollingsworth MA, Abdalla MY.
Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers. 2021; 13(9):2264.
https://doi.org/10.3390/cancers13092264
Chicago/Turabian Style
Ahmad, Iman M., Alicia J. Dafferner, Kelly A. O’Connell, Kamiya Mehla, Bradley E. Britigan, Michael A. Hollingsworth, and Maher Y. Abdalla.
2021. "Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma" Cancers 13, no. 9: 2264.
https://doi.org/10.3390/cancers13092264
APA Style
Ahmad, I. M., Dafferner, A. J., O’Connell, K. A., Mehla, K., Britigan, B. E., Hollingsworth, M. A., & Abdalla, M. Y.
(2021). Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers, 13(9), 2264.
https://doi.org/10.3390/cancers13092264